Ambetter contracts with multiple IROs depending on state
Wegovy was recently approved by the FDA to treat weight loss for individuals with a BMI of 30 or higher (considered the obese category) and individuals with an overweight BMI (25 - 30) who also have a weight-related comorbidity (high blood pressure, fatty liver disease, high cholesterol, etc.)
The comment deadline is a milestone in a longer process, not a cliff where compounded GLP-1 vanishes overnight
I created Picnik after discovering the life-changing difference that high-quality fats and other functional ingredients could have on physical health and mental clarity, said Naomi Seifter, founder and chief executive officer
Furthermore, GLP-1 injections have been shown to support heart health by reducing the risk of cardiovascular diseases, which are common among individuals with obesity
This review describes multiple roles of the gut microbiota and short-chain fatty acids in regulation of body weight and insulin sensitivity
